Alterations in metal homeostasis occur prior to canonical markers in Huntington disease

• Published in: Scientific reports Vol. 12; no. 1; p. 10373
• Main Authors: Pfalzer, Anna C., Yan, Yan, Kang, Hakmook, Totten, Melissa, Silverman, James, Bowman, Aaron B., Erikson, Keith, Claassen, Daniel O.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 20.06.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378/1689; 631/378/2632/1323; 631/378/87; Biology; Biomarkers; Cerebrospinal fluid; Copper; Disease; Heavy metals; Homeostasis; Humanities and Social Sciences; Humans; Huntingtin; Huntington Disease - cerebrospinal fluid; Huntington Disease - genetics; Huntington's disease; Huntingtons disease; Iron; Manganese; Metals; multidisciplinary; Mutants; Neurodegenerative diseases; Plasma; Science; Science (multidisciplinary); Zinc
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-14169-y

The importance of metal biology in neurodegenerative diseases such as Huntingtin Disease is well documented with evidence of direct interactions between metals such as copper, zinc, iron and manganese and mutant Huntingtin pathobiology. To date, it is unclear whether these interactions are observed in humans, how this impacts other metals, and how mutant Huntington alters homeostatic mechanisms governing levels of copper, zinc, iron and manganese in cerebrospinal fluid and blood in HD patients. Plasma and cerebrospinal fluid from control, pre-manifest, manifest and late manifest HD participants were collected as part of HD-Clarity. Levels of cerebrospinal fluid and plasma copper, zinc, iron and manganese were measured as well as levels of mutant Huntingtin and neurofilament in a sub-set of cerebrospinal fluid samples. We find that elevations in cerebrospinal fluid copper, manganese and zinc levels are altered early in disease prior to alterations in canonical biomarkers of HD although these changes are not present in plasma. We also evidence that CSF iron is elevated in manifest patients. The relationships between plasma and cerebrospinal fluid metal are altered based on disease stage. These findings demonstrate that there are alterations in metal biology selectively in the CSF which occur prior to changes in known canonical biomarkers of disease. Our work indicates that there are pathological changes related to alterations in metal biology in individuals without elevations in neurofilament and mutant Huntingtin.